Proshares UltraPro NASDAQ Biotechnology
UBIO
UBIO was delisted on the 27th of March, 2020.
1 hedge funds and large institutions have $13K invested in Proshares UltraPro NASDAQ Biotechnology in 2020 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 6 closing their positions.
83% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 6
86% less funds holding
Funds holding: 7 → 1 (-6)
100% less capital invested
Capital invested by funds: $3.23M → $13K (-$3.21M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Simplex Trading
Chicago,
Illinois
|
+$22.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$1.85M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.11M |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$166K |
| 4 |
CG
Cutler Group
San Francisco,
California
|
-$49K |
| 5 |
Morgan Stanley
New York
|
-$26K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Simplex Trading
Chicago,
Illinois
| $13K | +$22.1K | +784 | New |
|
|
2
Jane Street
New York
| – | -$1.85M | -56,492 | Closed |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$1.11M | -33,955 | Closed |
|
|
TRCT
4
Tower Research Capital (TRC)
New York
| – | -$166K | -5,075 | Closed |
|
|
CG
5
Cutler Group
San Francisco,
California
| – | -$49K | -1,521 | Closed |
|
|
6
Morgan Stanley
New York
| – | -$26K | -805 | Closed |
|
7
UBS Group
Zurich,
Switzerland
| – | -$2K | -55 | Closed |
|
UBIO Hedge Fund Activity: Q1 2020 in Review
1 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Proshares UltraPro NASDAQ Biotechnology (UBIO) for Q1 2020, worth a combined $13K — down 100% from $3.23M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of UBIO and 1 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Simplex Trading, opening a new position worth an estimated $22.1K. The largest seller was Jane Street, exiting entirely with an estimated $1.85M sold.
- 1 institutional investor held Proshares UltraPro NASDAQ Biotechnology (UBIO) as of Q1 2020, down from 7 in Q4 2019.
- Funds reported $13K of Proshares UltraPro NASDAQ Biotechnology stock for Q1 2020, down 100% quarter-over-quarter.
- 1 fund opened new Proshares UltraPro NASDAQ Biotechnology positions in Q1 2020 and 6 closed out, a net change of -5 holders.
- The largest Proshares UltraPro NASDAQ Biotechnology buyer in Q1 2020 was Simplex Trading, an estimated $22.1K added.
- The largest Proshares UltraPro NASDAQ Biotechnology seller in Q1 2020 was Jane Street, an estimated $1.85M sold.
Based on aggregated 13F filings for Q1 2020.